Endometriosis partners to discover personalised treatments
Drug Discovery World
JULY 3, 2023
PrecisionLife and the University of Oxford have signed a data access agreement to license the Oxford Endometriosis Gene (OXEGENE) dataset to develop new personalised treatments for endometriosis patients. We hope that the analysis of our data will lead to the development of precision medicines to improve the lives of patients.”
Let's personalize your content